Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis

Record ID 32006000879
English
Authors' objectives:

This report evaluates the clinical utility and cost-effectiveness of polysomnography (PSG) in the diagnosis and management of sleep disorders.

Authors' recommendations: Considerations for Policy Development Obesity, rather than obstructive sleep apnea (OSA), leads to cardiovascular consequences. Treating and preventing obesity would substantially reduce the economic burden associated with diabetes, hypertension, hyperlipidemia and OSA. Promotion of healthy weights may be achieved by a multisectorial approach as recommended by the Chief Medical Officer of Health for Ontario. Bariatric surgery has a major role in morbidly obese individuals (BMI > 35 kg/m2 and a comorbid condition, or BMI > 40 kg/m2). In January 2005, the Medical Advisory Secretariat completed an assessment of bariatric surgery, based on which the Ontario Health Technology Advisory Committee recommended an improvement in access to these surgeries for morbidly obese patients in Ontario. Habitual snorers with excessive daytime sleepiness have a high pretest probability of having OSA. These patients could be offered a therapeutic trial of continuous positive airway pressure (CPAP) to diagnose OSA, rather than a PSG. A majority of these patients are also obese and may benefit from weight loss. Thus, individualized weight loss programs should be offered; patients who are morbidly obese should be offered bariatric surgery. That said, in view of the identification of OSA in the past 30 years and that the understanding of its causes, consequences and optimal treatment are still under evolution, and further research is warranted to identify which patients should be screened for OSA.
Authors' methods: Review
Details
Project Status: Completed
Year Published: 2006
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Polysomnography
  • Snoring
  • Obesity
  • Sleep Apnea, Obstructive
  • Sleep Wake Disorders
Contact
Organisation Name: Medical Advisory Secretariat
Contact Address: Medical Advisory Secretariat, 20 Dundas Street West, 10th Floor, Toronto, ON M5G 2N6 CANADA. Tel: 416-314-1092l; Fax: 416-325-2364;
Contact Name: MASinfo.moh@ontario.ca
Contact Email: MASinfo.moh@ontario.ca
Copyright: Medical Advisory Secretariat, Ontario Ministry of Health and Long-Term Care
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.